Patent ID: 11897958
Assignee: BIO-TECHNE CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. The method of claim 2, wherein the monoclonal antibody comprises a monoclonal antibody produced by at least one of the following clones:
Ms x hVSIG4 528902.11 (ATCC Accession No. PTA-124187);
Ms x hVSIG4 528903.111 (ATCC Accession No. PTA-124188);
Ms x hVSIG4 528905.11 (ATCC Accession No. PTA-124189);
Ms x hVSIG4 528906.11 (ATCC Accession No. PTA-124178);
Ms x hVSIG4 528908.11 (ATCC Accession No. PTA-124179);
Ms x hVSIG4 528910.111 (ATCC Accession No. PTA-124180);
Ms x hVSIG4 528912.11 (ATCC Accession No. PTA-124181);
Ms x hVSIG4 528922.111 (ATCC Accession No. PTA-124182);
Ms x hVSIG4 528927.111 (ATCC Accession No. PTA-124183);
Rt x hVSIG4 489509.11 (ATCC Accession No. PTA-124184);
Rt x hVSIG4 489517.111 (ATCC Accession No. PTA-124185); and
Rt x hVSIG4 489518.11 (ATCC Accession No. PTA-124186).